Ladies and Gents, Allow Me to Introduce the Catalyst Calendar!

This is Day 4 of a four-part series. This is Day 4 of a four-part series. Yesterday, I explained how it’s possible for biotech traders to successfully trade every step along the drug approval highway, from initial product ideation… all the way to Phase 3 clinical trials. This is Day 4 of a four-part series. To view the previous days’ content, [click here.]( --------------------------------------------------------------- Yesterday, I explained how it’s possible for biotech traders to successfully trade every step along the drug approval highway, from initial product ideation... all the way to Phase 3 clinical trials. But to do that, you have to answer two questions: - When will each “catalyst event” happen? - What’s the likelihood that a drug will make it through its catalyst event? If you can answer those two questions, the world of biotech trading will be unlocked for you, my friend. Unluckily for most traders, answering that question is near impossible. Companies don’t always publish the dates of catalyst events, especially earlier-stage ones. And unless you’re a multidisciplinary biochemist, good luck trying to figure out the chances a drug has of passing its catalyst event. So what most biotech traders end up doing is nothing more than guessing. Which — as you can probably guess — rarely pans out well. But luckily for you, you don’t have to be most traders. Because for the past two years, I’ve been developing the most powerful trading strategy of my entire career. It allows me to pinpoint exactly when a catalyst event will hit... And the chances a drug has of making it through successfully. Armed with this information, my team and I have been able to score amazing gains like a 27% gain on Verrica Pharmaceuticals in January... A 32% windfall on Lipocine Inc... A 77% winner on Evoke Pharma... A 59% payday on Dova Pharmaceuticals... And many, many more. What is my strategy called? Well, I’m so glad you asked! I call it the Catalyst Calendar... And if you’re ready to start trading biotech successfully, tomorrow might very well be one of the GREATEST DAYS OF YOUR LIFE! Because I’m going to reveal every single detail about how the Catalyst Calendar works! You’ll discover exactly how it can help you get set up for massively successful biotech trades... Up to three times every single week... Four weeks every single month... And 12 months every single year! Yes, you heard me right. Armed with the Catalyst Calendar, you could score up to 144 big trade opportunities over the next year. So I hope you’re ready. And I want you to start thinking about what you would do with your life if you had the ability to score big trade wins over and over and over again. Would you quit your job and move somewhere warmer, maybe to a beach in South Florida? Or would you buy a lake house? Maybe you would live it up on an awesome vacation to Greece? Tomorrow, I’m going to give you the tools you need to start putting yourself on the path of your dreams. Whatever that path may be. I can’t wait to see you at the event. Remember, the summit starts tomorrow, May 20, at 3 p.m.. So please, please, PLEASE! [Mark your calendar.]( You do not want to be late and miss out on any of the valuable training I’m about to drop. You really could use it to start changing your life! I’ll be back in your inbox tomorrow morning with a couple more details about how to get ready for the summit. Until next time, [Keith's Sign off] Keith Kohl Investment Director, Catalyst Calendar P.S. Make sure you don’t forget to show up at 2 p.m. tomorrow. You can sign up for [text message alerts here]( if you need an extra reminder. --------------------------------------------------------------- If you no longer wish to receive updates from Catalyst Calendar you [may opt out here.]( Catalyst Calendar, Copyright © 2021, Angel Publishing, LLC., 3 E. Read Street, Baltimore, MD 21202. For customer service, please call 877-303-4529. All rights reserved. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Angel Publishing and Catalyst Calendar do not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors, and consultants of Angel Publishing may actively trade in the investments discussed in this newsletter. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. Unauthorized reproduction of this newsletter or its contents by xerography, facsimile, or any other means is illegal and punishable by law.